EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer

Andreas Spörlein, Christoph Becker, Joseph Berthelot, Valentin Burkhardt, Katharina Laubner, Mira Fink, Bernd Jänigen

European Archives of Oto-Rhino-Laryngology · 2026-03 · 283 (3) · 1931-1937

DOI: 10.1007/s00405-025-09929-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 22.12.2025. Verfasst von Andreas Spörlein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Medical Center - University of Freiburg, Freiburg, Germany. andreas.spoerlein@uniklinik-fr…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Freiburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Total thyroidectomy (TT) remains the standard surgical treatment of sporadic medullary thyroid cancer (sMTC), primarily due to the presumed risk of occult contralateral disease. However, recent evidence suggests that in selected patients, hemithyroidectomy (HT) may offer comparable oncologic outcomes. This retrospective study aimed to evaluate the prevalence of occult contralateral disease and to identify clinicopathological factors associated with disease-free survival (DFS).

Methods

We retrospectively analyzed all surgical patients with sMTC at a tertiary academic center (2013–2025), excluding patients with hereditary MTC, RET mutations, or clinical evidence of MEN2. Kaplan-Meier analysis with logrank testing was used to identify predictors of DFS.

Results

Forty-eight patients were included (66.7% female, median age 60.5 years). TT was performed in 44 patients (91.7%). Bilateral disease was present in five patients (11.4%), all detected on preoperative ultrasound. No cases of occult contralateral disease were found. During a median follow-up of 3.4 years, seven patients (14.6%) experienced recurrence. Advanced T stage, nodal involvement, distant metastases, lymphatic and vascular invasion, extracapsular extension, and male sex were all significantly associated with reduced DFS (all p < 0.05). Persistent postoperative calcitonin elevation (> 2 pg/mL) strongly predicted recurrence ( p < 0.001), whereas baseline calcitonin > 500 pg/mL did not.

Conclusion

Occult contralateral disease in sMTC is rare when high-quality preoperative ultrasound is available. In selected patients with unifocal, node-negative tumors and favorable pathology, HT combined with structured calcitonin monitoring may be an oncologically safe, less morbid alternative. These findings support individualized, risk-adapted surgical strategies in sMTC. Prospective validation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroidectomyCarcinoma, NeuroendocrineHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultDisease-Free Survival

Stichwörter der Autor:innen

Medullary thyroid carcinomaPersonalized treatmentPrognostic factorsQuality of lifeRisk-adapted surgeryThyroidectomy

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head and Neck Surgery, Medical Center - University of Freiburg, Freiburg, Germany. andreas.spoerlein@uniklinik-freiburg.de.
  • Department of Otorhinolaryngology - Head and Neck Surgery, Medical Center - University of Freiburg, Freiburg, Germany.
  • Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of General and Visceral Surgery, Medical Center - University of Freiburg, Freiburg, Germany.

Förderung

  • Universitätsklinikum Freiburg

Zitieren

APA

Spörlein, A., Becker, C., Berthelot, J., Burkhardt, V., Laubner, K., Fink, M., & Jänigen, B. (2026). Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer. European Archives of Oto-Rhino-Laryngology, 283(3), 1931-1937. https://doi.org/10.1007/s00405-025-09929-1

Vancouver

Spörlein A, Becker C, Berthelot J, Burkhardt V, Laubner K, Fink M, et al. Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer. European Archives of Oto-Rhino-Laryngology. 2026;283(3):1931-1937. doi:10.1007/s00405-025-09929-1

BibTeX
@article{Sprlein2026,
  author = {Spörlein, Andreas and Becker, Christoph and Berthelot, Joseph and Burkhardt, Valentin and Laubner, Katharina and Fink, Mira and Jänigen, Bernd},
  title = {Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {3},
  pages = {1931--1937},
  doi = {10.1007/s00405-025-09929-1}
}
Kostenlos starten →